CMS Investment Quality Review (00867.HK)

Data timestamp: 2026-08-03 22:12 UTC
Quality score: 75/100
Valuation position: current price/base FV 1.46
Final signal: WATCHLIST

Core Conclusion

CMS stays on the watchlist but is not buyable. HKD11.84 is 1.46x base and conservative FV of HKD8.12. The quality score is just at the watchlist line, so the burden of proof is higher than for stronger compounders.

Business Breakdown

Five-year revenue CAGR is 5.7%, with latest-year revenue of CNY8.21bn. The portfolio and commercialization model can generate cash, but product life-cycle, policy pressure, and evidence depth require caution.

Business Quality

The 75/100 score reflects positive but not exceptional economics. Latest-year FCF was CNY0.25bn. Five-year average ROE was 8.6% and average ROIC was 9.7%, which makes valuation discipline especially important.

Financial Audit

Fiscal 2025 revenue was CNY8.21bn, net profit CNY1.49bn, operating cash flow CNY0.76bn, capex CNY0.51bn, and FCF CNY0.25bn. Five-year FCF/net income was 0.74 and OCF/net income was 0.88. Latest net cash was CNY2.01bn.

Valuation

The conservative and base cases both produce HKD8.12 per share, using normalized FCF of CNY1.65bn, an 8.0x multiple, and low-to-zero growth. The optimistic case uses 1.5% growth and 11.0x, producing HKD10.47. Current price/base FV of 1.46 leaves no margin of safety.

Buy And Tracking Discipline

The action is watch. A buy requires price/base FV below 0.70, quality score staying at or above 75, better evidence on product durability, and stronger cash conversion.

Risk Review

Risks include volume-based procurement, product concentration, licensing economics, working-capital volatility, pipeline execution, and capital allocation. If FCF conversion weakens again or net cash falls materially, the score and FV should be reduced.

Data Sources

The memo relies on public market and financial data, company filings or investor-relations materials, ChinaBond yield data, and public FX data where applicable. This is research only, not personalized investment advice.